Revolutionizing viral disease treatment: PROTACs therapy could be the ultimate weapon of the future

Over the last several years, a novel technique for disassembling proteins has evolved; this process is referred to as PROteolysis TArgeting Chimaeras (PROTACs).This method uses tiny molecules with multiple functions to promote the ubiquitination of target proteins, facilitating their degradation by the proteasome.PROTACs are a technique for breaking down proteins.Cancer, immune system disorders, viral infections, and neurological problems are some of the many conditions that may benefit from the therapeutic use of PROTACs.Scientists have discovered a method for the catalytic, rapid, and reversible breakdown of compounds.Recently, researchers have begun exploring the idea of employing PROTACs to treat viral infections, expanding their usage of the technology beyond its original use in cancer therapy.The potential use of PROTACs in treating infectious illnesses caused by viruses is a rapidly growing field of investigation.PROTACs may provide a game-changing approach to treating viral infections.Essential viral proteins would be degraded selectively as part of this technique.This letter emphasizes the need to develop novel strategies, learn more about the architectures of viral proteins, and design effective PROTACs to combat a wide range of viral diseases.Research potential for PROTACs in the context of viral infections is also discussed.Infectious diseases caused by viruses originate in the virus's ability to invade and replicate inside host cells.Several viral proteins are exciting targets for antiviral treatment because of their essential roles in the virus's life cycle.PROTACs provide a novel strategy when targeting these viral proteins since they can destroy them rather than only suppress their activity.